169 related articles for article (PubMed ID: 10666191)
21. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
[TBL] [Abstract][Full Text] [Related]
22. Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia.
Manocha S; Matrai Z; Osthoff M; Carter A; Pettitt AR
Leuk Lymphoma; 2003 May; 44(5):797-800. PubMed ID: 12802916
[TBL] [Abstract][Full Text] [Related]
23. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.
Dorrell C; Gan OI; Pereira DS; Hawley RG; Dick JE
Blood; 2000 Jan; 95(1):102-10. PubMed ID: 10607692
[TBL] [Abstract][Full Text] [Related]
24. Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
Morikawa K; Torii I; Morikawa S
Scand J Immunol; 2002 Jan; 55(1):44-52. PubMed ID: 11841691
[TBL] [Abstract][Full Text] [Related]
25. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia.
Lin K; Sherrington PD; Dennis M; Matrai Z; Cawley JC; Pettitt AR
Blood; 2002 Aug; 100(4):1404-9. PubMed ID: 12149224
[TBL] [Abstract][Full Text] [Related]
26. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
27. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia.
Morabito F; Mangiola M; Oliva B; Stelitano C; Callea V; Deaglio S; Iacopino P; Brugiatelli M; Malavasi F
Leuk Res; 2001 Nov; 25(11):927-32. PubMed ID: 11597727
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II.
Bauvois B; Durant L; Laboureau J; Barthélémy E; Rouillard D; Boulla G; Deterre P
J Interferon Cytokine Res; 1999 Sep; 19(9):1059-66. PubMed ID: 10505750
[TBL] [Abstract][Full Text] [Related]
30. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
31. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
[TBL] [Abstract][Full Text] [Related]
32. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.
Fais F; Sellars B; Ghiotto F; Yan XJ; Dono M; Allen SL; Budman D; Dittmar K; Kolitz J; Lichtman SM; Schulman P; Schuster M; Vinciguerra VP; Rai K; Stevenson FK; Gregersen PK; Ferrarini M; Chiorazzi N
J Clin Invest; 1996 Oct; 98(7):1659-66. PubMed ID: 8833916
[TBL] [Abstract][Full Text] [Related]
33. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous immunoglobulin-producing capacity of cultures from lupus patients and normal donors following depletion of cells expressing CD19 or CD38.
Bourne T; Zukowska-Cooper M; Salaman MR; Seifert MH; Isenberg DA
Clin Exp Immunol; 1998 Mar; 111(3):611-6. PubMed ID: 9528907
[TBL] [Abstract][Full Text] [Related]
35. Human peripheral B cell development. sIgM-IgD+CD38+ hypermutated germinal center centroblasts preferentially express Ig lambda light chain and have undergone mu-to-delta switch.
Arpin C; de Bouteiller O; Razanajaona D; Brière F; Banchereau J; Lebecque S; Liu YJ
Ann N Y Acad Sci; 1997 Apr; 815():193-8. PubMed ID: 9186655
[No Abstract] [Full Text] [Related]
36. MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.
Rozenfeld-Granot G; Toren A; Amariglio N; Nagler A; Rosenthal E; Biniaminov M; Brok-Simoni F; Rechavi G
Exp Hematol; 2002 May; 30(5):473-80. PubMed ID: 12031654
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
Xiao M; Oppenlander BK; Dooley DC
Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative signals transduced through surface immunoglobulins in human B cells.
Mayumi M; Ishigami T; Kanazashi S; Yamaoka K; Sumimoto S; Heike T; Katamura K; Hata D; Kim KM
J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 2):612-9. PubMed ID: 8083469
[TBL] [Abstract][Full Text] [Related]
39. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation.
Lebecque S; de Bouteiller O; Arpin C; Banchereau J; Liu YJ
J Exp Med; 1997 Feb; 185(3):563-71. PubMed ID: 9053456
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
